메뉴 건너뛰기




Volumn 21, Issue 3, 2005, Pages 236-241

A comparison of therapeutic regimens containing moxifloxacin 0.5% ophthalmic solution and gatifloxacin 0.3% ophthalmic solution for surgical prophylaxis in patients undergoing LASIK or LASEK

Author keywords

[No Author keywords available]

Indexed keywords

BION TEARS; DICLOFENAC; EYE DROPS; GATIFLOXACIN; KETOROLAC TROMETAMOL; MOXIFLOXACIN; PREDNISOLONE ACETATE;

EID: 21644457591     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2005.21.236     Document Type: Article
Times cited : (22)

References (10)
  • 1
    • 0036206726 scopus 로고    scopus 로고
    • Fourth-generation fluoroquinolones: New weapons in the arsenal of ophthalmic antibiotics
    • Mather, R., Karenchak, L.M., Romanowski, E.Q., and Kowalski, R.P. Fourth-generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics. Am J Ophthalmol. 133:463-466, 2002.
    • (2002) Am. J. Ophthalmol. , vol.133 , pp. 463-466
    • Mather, R.1    Karenchak, L.M.2    Romanowski, E.Q.3    Kowalski, R.P.4
  • 2
    • 0036724716 scopus 로고    scopus 로고
    • Fluoroquinolone resistance among gram-positive cocci
    • Hooper, D.C. Fluoroquinolone resistance among gram-positive cocci. Lancet Inf. Dis. 2:530-538, 2002.
    • (2002) Lancet Inf. Dis. , vol.2 , pp. 530-538
    • Hooper, D.C.1
  • 3
    • 0042828942 scopus 로고    scopus 로고
    • Gatifloxacin and moxifloxacin: An in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates
    • Kowalski R.P., Dhaliwal, D.K., Karenchak, L.M., Romanowski, E.G., Mah, F.S., Ritterband, D.C., and Gordon, Y.J. Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates. Am J. Ophthalmol. 136:500-505, 2003.
    • (2003) Am. J. Ophthalmol. , vol.136 , pp. 500-505
    • Kowalski, R.P.1    Dhaliwal, D.K.2    Karenchak, L.M.3    Romanowski, E.G.4    Mah, F.S.5    Ritterband, D.C.6    Gordon, Y.J.7
  • 7
    • 1542511330 scopus 로고    scopus 로고
    • Topical antibacterial therapy for mycobacterial keratitis: Potential for surgical prophylaxis and treatment
    • Abshire, R., Cockrum, P., Crider, J., and Schlech, B. Topical antibacterial therapy for mycobacterial keratitis: potential for surgical prophylaxis and treatment. Clin. Ther. 26:191-196, 2004.
    • (2004) Clin. Ther. , vol.26 , pp. 191-196
    • Abshire, R.1    Cockrum, P.2    Crider, J.3    Schlech, B.4
  • 8
    • 14644444121 scopus 로고    scopus 로고
    • Penetration of topically applied gatifloxacin 0.3%, moxifloxacin 0.5%, and ciprofloxacin 0.3% into the aqueous humor
    • Solomon, R., Donnenfeld, E.D., Perry H.D., Snyder, R.W., Nedrud, C., Jonathan J., and Bloom, A. Penetration of topically applied gatifloxacin 0.3%, moxifloxacin 0.5%, and ciprofloxacin 0.3% into the aqueous humor. Ophthalmology 412:466-469, 2005.
    • (2005) Ophthalmology , vol.412 , pp. 466-469
    • Solomon, R.1    Donnenfeld, E.D.2    Perry, H.D.3    Snyder, R.W.4    Nedrud, C.5    Jonathan, J.6    Bloom, A.7
  • 9
    • 32644476356 scopus 로고    scopus 로고
    • Evaluation of moxifloxacin and ciprofloxacin concentrations in human conjunctival tissue following administration of moxifloxacin 0.5% (Vigamox™) and ciprofloxacin 0.3% (Ciloxan™) ophthalmic solution
    • in press
    • Wagner, R.S., Cockrum, P.C., Abelson, M.B., Shapiro, and Torkildsen, G.A. Evaluation of moxifloxacin and ciprofloxacin concentrations in human conjunctival tissue following administration of moxifloxacin 0.5% (Vigamox™) and ciprofloxacin 0.3% (Ciloxan™) ophthalmic solution. Arch. Ophthalmol. (in press).
    • Arch. Ophthalmol.
    • Wagner, R.S.1    Cockrum, P.C.2    Abelson, M.B.3    Shapiro4    Torkildsen, G.A.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.